Gland Pharma Limited — Important, 26-02-2025: Updates

The ESOP Compensation Committee of Gland Pharma has allotted 4,700 equity shares of Re. 1 each to employees upon exercising their stock options as per the Employee Stock Options Scheme, 2019. This allotment increases the company's issued, subscribed, and paid-up share capital to Rs. 164.76 crore, comprising 16,47,56,423 equity shares. The exercise price for these shares was Rs. 542 each, with a premium of Rs. 541 per share. This development is a part of Gland Pharma's strategy to incentivize employee performance and retain talent, which could positively impact the company's long-term growth trajectory. Investors should monitor the company’s performance following this issuance, as employee ownership can enhance alignment with shareholder interests.